Labrador, Aldrin L.

HRN: 04-15-50  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/23/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
03/23/2026
03/29/2026
IV
2.25g
Q8h
CAP-HR
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines